Weight Management News and Research

RSS

Strong heart health lowers long-term death risk in cancer survivors

Higher Life’s Simple 7 cardiovascular health scores were associated with lower long-term all-cause and cancer mortality in cancer survivors from a large Italian cohort. Inflammation, resting heart rate, and vitamin D statistically explained a substantial share of these associations, supporting shared cardiometabolic pathways across cancer and cardiovascular disease.

17 Dec 2025

A new trial investigates whether the MIND diet can be scaled for obesity management

This study protocol outlines a 12-week randomized trial testing whether a MIND diet intervention is feasible, acceptable, and sustainable for adults with obesity in Sweden. It will generate preliminary evidence on adherence, mental well-being, and gut microbiota changes to inform larger efficacy trials.

14 Dec 2025

Why green tea delivers the strongest health benefits

This review examines tea's health effects, highlighting green tea's benefits for heart health and cognition, and warns about risks in processed tea products.

1 Dec 2025

Understanding tea's health benefits and risks

The review confirms that tea, particularly green tea, plays a crucial role in preventing cardiovascular diseases (CVDs), obesity, diabetes, and certain types of cancer.

1 Dec 2025

Semaglutide helps older adults lose weight without immediate bone loss

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to assess its effects on bone health.

1 Dec 2025

Overweight boys hit puberty earlier than peers

Childhood obesity accelerates puberty in boys, with heavier children showing earlier testicular enlargement and pubic hair development, study finds.

1 Dec 2025

Ultra-processed foods linked to rise in prediabetes risk

The study reveals that ultra-processed foods heighten prediabetes risk in young adults with obesity history, stressing the importance of healthy eating habits.

25 Nov 2025

Development of a polygenic risk score for pelvic organ prolapse in Chinese women

Pelvic organ prolapse (POP), a condition whose development is shaped by both genetic and clinical risk factors, significantly impairs women's quality of life, yet genetic insights into non-European populations and comprehensive risk models that integrate genetic and clinical data remain insufficiently explored.

24 Nov 2025

Tirzepatide reveals a brain signal that predicts returning food preoccupation

Researchers implanted electrodes in the human nucleus accumbens to track brain activity during severe food preoccupation in an individual taking tirzepatide. They found that a delta–theta biomarker disappeared during symptom-free periods and re-emerged weeks before relapse, suggesting a possible neural marker of vulnerability to dysregulated eating.

18 Nov 2025

Maternal obesity raises childhood epilepsy and disability risks, new study shows

Higher maternal BMI before pregnancy is linked to increased risks of epilepsy and intellectual disability in young children, even after extensive adjustment for maternal and neonatal factors. Associations with autism spectrum disorder and ADHD disappear after full adjustment, highlighting the potential mediating role of perinatal complications.

17 Nov 2025

Family support helped adults in rural China to reduce blood pressure levels

New research found family support helped adults in rural China reduce their blood pressure.

13 Nov 2025

What diet do people with type 2 diabetes really want? Study reveals flexibility beats strict meal plans

A large UK survey of adults with type 2 diabetes found that most prefer flexible, food-based diets—particularly moderate calorie restriction or low-carbohydrate plans, over formula-based regimens. Preferences varied by age, lifestyle, and desired outcomes, underscoring the need for personalized dietary support.

11 Nov 2025

Diabetes drugs semaglutide and tirzepatide show real-world heart benefits

In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack and stroke risk versus sitagliptin, while tirzepatide performed comparably to dulaglutide and semaglutide over one year.

10 Nov 2025

How gut microbes shape sleep: New review reveals microbiome clues to insomnia and apnea

A new Brain Medicine review maps how gut microbes influence sleep disorders, from insomnia and sleep apnea to circadian disruption, via bile acids, neurotransmitters, and immune pathways. The findings highlight gut-driven targets for improving sleep quality through diet, probiotics, and microbiome modulation.

5 Nov 2025

Do GLP-1 drugs cause cancer? New review says no, may even protect

A comprehensive review in The Journal of Clinical Investigation finds no overall link between GLP-1 receptor agonists and increased cancer risk, countering early safety concerns. Instead, evidence suggests possible protective effects for certain cancers, supported by metabolic and immune-modulating mechanisms.

4 Nov 2025

Skipping breakfast has little impact on mental performance, research shows

Skipping breakfast or practicing intermittent fasting is unlikely to cloud most adults' thinking in the short term, according to research published by the American Psychological Association.

3 Nov 2025

WHO reviews highlight limited long-term data on GLP-1 drug safety

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health Organization (WHO) to inform upcoming guidelines on the use of these drugs to treat obesity.

30 Oct 2025

Obesity’s health risks shift with age and sex, new genetic study reveals

Using a new time-resolved Mendelian randomization approach in over 360,000 UK Biobank participants, Karlsson et al. revealed that the causal impact of obesity changes across life, with distinct age- and sex-specific risk patterns for diabetes, heart disease, atrial fibrillation, and osteoarthritis.

27 Oct 2025

AI-powered app matches human-led programs in diabetes prevention

Researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health report that an AI-powered lifestyle intervention app for prediabetes reduced the risk of diabetes similarly to traditional, human-led programs in adults.

27 Oct 2025

Pain resilience affects physical activity independently of pain

Pain affects activity levels, but how individuals understand and act in the face of pain can make a difference, a new study from the University of Portsmouth has found.

23 Oct 2025